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Background: Gastrointestinal stromal tumors of the alimentary tract may present with severe bleeding. Localization
and treatment of obscure gastrointestinal bleeding is challenging in cases of negative bi-directional endoscopy.
Case presentation: A previously healthy 64-year-old Caucasian female presented with clinical signs of active
gastrointestinal bleeding. Esophagogastroduodenoscopy was normal, and colonoscopy revealed passage of blood
from the small bowel. Computerized tomography angiography demonstrated a hypervascular lesion with active
extravasation located in the jejunum. Angiography of the superior mesenteric artery revealed a focal hypervascular
mass in the jejunum, and super selective distal coil embolization of the feeding vessel was performed. When the
patient was taken for laparoscopic exploration, a 2.5 cm tumor arising from the anti-mesenteric border of the proximal
jejunum was identified and resected with primary anastomosis. Pathological results demonstrated a gastrointestinal
stromal tumor with a low proliferation index of 1%. Small erosions in the adjacent mucosa confirmed the locus of
bleeding.
Conclusions: Computerized tomography is a useful tool for initial diagnosis of submucosal alimentary tumors in
patients with obscure but clinically overt gastrointestinal bleeding. Selective angiography, following positive
computerized tomography findings, is an important modality to allow both localization and hemostasis in actively
bleeding small bowel tumors, but the procedure carries the risk of bowel necrosis. Complete surgical resection
remains the mainstay for treatment of gastrointestinal stromal tumors.
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Gastrointestinal stromal tumors (GISTs) are rare mesen-
chymal neoplasms of the gastrointestinal (GI) tract. They
account for 0.3 to 0.5% of all GI tumors [1] and may be
found anywhere along the GI tract, but predominantly
develop in the stomach and small intestine [2]. GISTs
usually present with vague abdominal symptoms; severe
overt bleeding is a rare presentation of this disease [2].
Although there are adjuvant medical therapies, only
complete surgical resection is curative [3].
In this paper we report a case of obscure, overt GI
bleeding due to a jejunal GIST. We discuss our pre-
operative diagnostic steps and management and provide* Correspondence: rbalam@hadassah.org.il
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bleeding.Case presentation
A previously healthy 64-year-old Caucasian female pre-
sented to the emergency department (ED) with melena
and syncope. She showed signs of hypovolemia with a
heart rate of 110 beats per minute and a blood pressure
of 100/50 mmHg. Digital rectal examination demon-
strated hematochezia. A nasogastric tube was inserted
and revealed clear gastric contents. Initial hemoglobin
and hematocrit were 9 gr% and 26% respectively. Platelet
count was normal. Subsequent blood counts demon-
strated a drop in hemoglobin and hematocrit to 7 gr%
and 20%, accompanied by a mild thrombocytopenia of
100*109/L. She received two units of packed red bloodtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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itors. Esophagogastroduodenoscopy (EGD) was normal up
to the third part of the duodenum, while colonoscopy
demonstrated passage of blood from the terminal ileum
without identifying the source of bleeding. Computerized
tomography angiography (CTA) revealed a mass lesion
in the jejunum with active intravenous contrast extrava-
sation (Figure 1). The patient’s unstable condition deter-
mined immediate intervention. In order to accurately
mark the location of the lesion, thereby avoiding an ex-
ploratory laparotomy, the patient underwent diagnostic
angiography of the superior mesenteric artery arcade sys-
tem, revealing a hypervascular jejunal mass (Figure 2). Se-
lective metal coil embolization of the feeding vessel was
performed. On the same day the patient was taken to the
operating theatre for a laparoscopic exploration of the ab-
domen. A 2.5 cm tumor arising from the anti-mesenteric
border of the proximal jejunum was identified (Figure 3).
The embolization coil was visualized adjacent to the bowel
wall, with segmental ischemic discoloration of the serosa.
Small bowel resection with primary anastomosis was
performed. Postoperative course was uneventful. Path-
ology results showed a CD 117 positive gastrointestinal
stromal tumor with a low MIB-1 proliferation index of
1% (Figure 4). Surgical margins were free of tumor. Small
erosions were noted in the adjacent mucosa, the most
probable source of bleeding.
The patient was discharged in good overall medical con-
dition. Medical therapy (tyrosine kinase inhibitors) was
not started due to the low chance of GIST recurrence.Figure 1 Computerized tomography angiography demonstrated a hy
tumor. Upon close observation contrast extravasation into the lumen can bConclusions
GIST is the most common sarcoma of the GI tract with
an incidence of 10–20 per million, accounting for 0.3-
0.5% of all GI tumors [1,4]. GISTs are most commonly
found in the stomach (60%), followed by the small intes-
tine (30%), large bowel (5%), and rectum (5%) [1,2,5].
These tumors were once considered to be leiomyomas,
leiomyosarcomas, leiomyoblastomas or schwanommas,
based on their histology; however, it has become evident
that these tumors are a distinct entity caused by specific
gain of function mutations in the C-Kit, tyrosine kinase
protein [6]. It has been proposed that the cellular origin
of GISTs is the interstitial cell of Cajal, the pacemaker of
the alimentary tract [5]. Cajal cells exhibit both neuronal
and smooth muscle cell histological features that are fre-
quently found in GIST.
The majority of patients with GIST present with vague
symptoms such as abdominal pain, GI bleeding or ab-
dominal fullness [2].
Obscure GI bleeding (OGIB) is defined as bleeding
which persists despite negative findings in bi-directional
endoscopy [7]. OGIB can be divided into two types:
overt, when bleeding is clinically evident as in our case;
and occult, when the manifestation of bleeding is anemia
or positive fecal occult blood. Pathological processes
along the entire GI tract can cause OGIB.
Video capsule endoscopy (VCE) is considered the pre-
ferred diagnostic tool in these patients because of its high
sensitivity [7,8]; due to the time it takes to perform the test
and analyze the video footage, however, VCE is often not apervacularized small bowel tumor. The arrow is pointing to the
e seen.
Figure 2 Diagnostic angiography revealed a hypervascularized jejunal mass.
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case presented here. Additionally, double balloon assisted
enteroscopy (DBE) and spiral enteroscopy can be per-
formed. The diagnostic yield of DBE for small bowel mes-
enchymal tumors has been reported to be nearly 90% [9],
but this case series included only one patient with overt
bleeding. A labeled red blood cell nuclear scan can detect
a source of bleeding that has a low rate of blood loss (less
than 0.5 ml/min), but poorly demonstrates the anatomic
location of the bleeding source. A labeled pertechnetate or
Meckel’s scan is useful in diagnosing Meckel’s diverticu-
lum as the bleeding source, but may show false negative
results during active bleeding [7]. Angiography is useful in
detecting active bleeding with rates above 0.5 ml/min, as
well as vascular lesions not actively bleeding. The main
advantage of angiography over other modalities is the abil-
ity to treat as well as diagnose OGIB. Due to the invasive-
ness and potential complications, exploratory surgery is a
last resort for detecting the cause and location of OGIB.
Any of the aforementioned modalities can be combined
in the work up and diagnosis of OGIB. Current treat-
ment recommendations include surgical excision with
or without imatinib mesylate therapy, depending on the
likelihood of recurrence.Our patient presented with symptomatic GI bleeding.
Endoscopy was normal and colonoscopy demonstrated
passage of blood without finding a bleeding source. The
combination of these findings led to suspicion of a small
intestinal bleeding source. Computerized tomography (CT)
enterography or angiography is a useful tool that can ac-
curately localize a bleeding source. Some authors argue
that CT should be part of the routine diagnostic work
up of small bowel occult GI bleeding, and may be more
sensitive than VCE in select cases [8]. Additionally, CT
is often more readily available than capsule endoscopy
in certain clinical settings. Both tests are considered ac-
ceptable third-line investigations in the diagnosis of ob-
scure GI bleeding following bi-directional endoscopy [7].
Angiography was used both to treat acute bleeding, by
placement of a coil in the feeding vessel, and to mark the
location of the bleeding lesion for upcoming surgery. Dur-
ing surgery an exophytic tumor of the jejunum was seen
with segmental ischemic discoloration of the serosa.
We believe that this case report of an uncommon eti-
ology of obscure GI bleeding demonstrates both the im-
portance of CT in the diagnosis of small bowel obscure
bleeding and the efficacy of angiography in addition to
surgery in the treatment of small bowel obscure bleeding.
Figure 4 Pathology of the tumor was consistent with gastrointestinal stromal tumor. Small intestine with an intramural gastrointestinal
stromal tumor, causing (arrows) ischemic erosion of the overlying mucosa (Hematoxylin and Eosin, original magnification X40). The tumor is
composed of (inset a) fascicles of spindle cells with bland nuclei, presenting (inset b) immunoreactivity for CD117 (a - Hematoxylin and Eosin,
original magnification X200, b – CD117, original magnification X200).
Figure 3 Antimesenteric jejunal tumor found during surgery.
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of small bowel GIST. CT is a useful tool for initial diagno-
sis and quick localization of submucosal alimentary tumors
in patients with active bleeding. Selective embolization is
an important diagnostic and therapeutic modality in ac-
tively bleeding small bowel GIST, but carries the risk of
bowel necrosis. Complete surgical resection remains the
mainstay of treatment of GIST.
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